These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20848185)

  • 1. Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort study.
    Fitzal F; Riedl O; Mittlböck M; Dubsky P; Bartsch R; Steger G; Jakesz R; Gnant M
    Breast Cancer Res Treat; 2011 May; 127(1):121-8. PubMed ID: 20848185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy increases the rate of breast conservation in lobular-type breast cancer patients.
    Fitzal F; Mittlboeck M; Steger G; Bartsch R; Rudas M; Dubsky P; Riedl O; Jakesz R; Gnant M
    Ann Surg Oncol; 2012 Feb; 19(2):519-26. PubMed ID: 21743980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
    Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score.
    Huang EH; Strom EA; Perkins GH; Oh JL; Chen AM; Meric-Bernstam F; Hunt KK; Sahin AA; Hortobagyi GN; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):352-7. PubMed ID: 16887286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early response to neo-adjuvant chemotherapy in carcinoma of the breast predicts both successful breast-conserving surgery and decreased risk of ipsilateral breast tumor recurrence.
    Ishitobi M; Komoike Y; Motomura K; Koyama H; Inaji H
    Breast J; 2010; 16(1):9-13. PubMed ID: 19929889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
    Cance WG; Carey LA; Calvo BF; Sartor C; Sawyer L; Moore DT; Rosenman J; Ollila DW; Graham M
    Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic Index.
    Ishitobi M; Ohsumi S; Inaji H; Ohno S; Shigematsu H; Akiyama F; Iwase T; Akashi-Tanaka S; Sato N; Takahashi K; Oura S
    Cancer; 2012 Sep; 118(18):4385-93. PubMed ID: 22252882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast-conserving therapy after neoadjuvant chemotherapy: long-term results.
    Beriwal S; Schwartz GF; Komarnicky L; Garcia-Young JA
    Breast J; 2006; 12(2):159-64. PubMed ID: 16509842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast-conserving therapy for centrally located breast cancer.
    Fitzal F; Mittlboeck M; Trischler H; Krois W; Nehrer G; Deutinger M; Jakesz R; Gnant M
    Ann Surg; 2008 Mar; 247(3):470-6. PubMed ID: 18376192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902.
    van Nes JG; Putter H; Julien JP; Tubiana-Hulin M; van de Vijver M; Bogaerts J; de Vos M; van de Velde CJ;
    Breast Cancer Res Treat; 2009 May; 115(1):101-13. PubMed ID: 18484198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients.
    Fitzal F; Riedl O; Wutzl L; Draxler W; Rudas M; Pluschnig U; Handl-Zeller L; Dubsky P; Bachleitner-Hofmann T; Steger G; Jakesz R; Gnant M
    Breast Cancer Res Treat; 2007 May; 103(1):45-52. PubMed ID: 17417725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving treatment strategies for inflammatory breast cancer: a population-based survival analysis.
    Panades M; Olivotto IA; Speers CH; Shenkier T; Olivotto TA; Weir L; Allan SJ; Truong PT
    J Clin Oncol; 2005 Mar; 23(9):1941-50. PubMed ID: 15774787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary operations are frequently required to complete the surgical phase of therapy in the era of breast conservation and sentinel lymph node biopsy.
    Mullenix PS; Cuadrado DG; Steele SR; Martin MJ; See CS; Beitler AL; Carter PL
    Am J Surg; 2004 May; 187(5):643-6. PubMed ID: 15135683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤ 40 years.
    van der Sangen MJ; van de Wiel FM; Poortmans PM; Tjan-Heijnen VC; Nieuwenhuijzen GA; Roumen RM; Ernst MF; Tutein Nolthenius-Puylaert MC; Voogd AC
    Breast Cancer Res Treat; 2011 May; 127(1):207-15. PubMed ID: 20703938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.
    Levy A; Borget I; Bahri M; Arnedos M; Rivin E; Vielh P; Balleyguier C; Rimareix F; Bourgier C
    Breast J; 2014; 20(4):381-7. PubMed ID: 24890310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer?
    Parker CC; Ampil F; Burton G; Li BD; Chu QD
    Surgery; 2010 Aug; 148(2):386-91. PubMed ID: 20580045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis.
    Huang EH; Strom EA; Valero V; Fornage B; Perkins GH; Oh JL; Yu TK; Tereffe W; Woodward WA; Hunt KK; Meric-Bernstam F; Sahin AA; Bedrosian I; Hortobagyi GN; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):490-6. PubMed ID: 17236970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy.
    Shen J; Valero V; Buchholz TA; Singletary SE; Ames FC; Ross MI; Cristofanilli M; Babiera GV; Meric-Bernstam F; Feig B; Hunt KK; Kuerer HM
    Ann Surg Oncol; 2004 Sep; 11(9):854-60. PubMed ID: 15313733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.